Loading the map…

Performing arts · South Croydon, London

Sceneuk

Sceneuk Ltd

Cash down 48%ActiveLatest figures: 2026Abridged accountsCompany only5 years on the register

Private limited company registered in South Croydon, classed under “Performing arts”.

Headline figures

FY to Jan 2026 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

Retained reserves

For subscribers

What the numbers say

3 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£20222023202420252026
Profit after tax—
Turnover
Net assets
Cash
Employees
Retained reserves

Every figure for all 5 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

Balance sheet and ratios

From the filed balance sheets · £

Balance sheet2023202420252026
Current assets
of which debtors
of which cash
Creditors due within a year
Net current assets
Net assets
Ratios
Current ratioCurrent assets for every £1 owed within a year
Cash ratioCash for every £1 owed within a year

6 balance-sheet lines and 2 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Questions people ask

›What does Sceneuk do?

Private limited company registered in South Croydon, classed under “Performing arts”.

›How much turnover does Sceneuk make?

Answered in the full report

›Is Sceneuk profitable?

Sceneuk's profit isn't public: small companies may file without a profit and loss account.

›How many people work at Sceneuk?

Answered in the full report

›Where is Sceneuk based?

Its registered office is Flat 1, 118 Selsdon Road, South Croydon, London, CR2 6PG, in South Croydon, London.

›When was Sceneuk founded?

Sceneuk Ltd was incorporated on 18 January 2021.

›Is Sceneuk still trading?

The register lists Sceneuk Ltd as active.